ScienceDex / Researcher record
Ma, Dangshe
- Progenics Pharmaceuticals, Inc. (no department on record)
From the FY2004 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2004
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2003 | $259,089 | 1 | #21,236 |
| 2004 | $1,387,670 | 3 | #2,880 |
| 2005 | $1,231,148 | 2 | #3,568 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20031 record
- FY2004 · selected3 records
- FY20052 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2003 through FY2005Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2004 award records by amount
NIH award records listing Ma, Dangshe as a PI. Multi-PI records show the full award amount for context.
- 2R44CA096075-03R44Contact PIHuman PSMA MAb Radioimmunotherapy for Prostate Cancer$891.9Kaward amount
- 1R43CA107653-01R43Contact PIPSMA-Targeted Immunotoxins for Prostate Cancer Therapy$281.2Kaward amount
- 5R43CA099402-02R43Contact PINovel Human Anti-CD19 Antibodies for Lymphoma Therapy$214.5Kaward amount
Award organization
Organizations that administered FY2004 awards listing Ma, Dangshe as a PI.
FY2004 award administered by Progenics Pharmaceuticals, Inc. ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2003First NIH AwardProgenics Pharmaceuticals, Inc.
- 2004$500K Cumulative Funding
- 2004$1M Cumulative Funding
- 2004Entered Top 50% NationallyRanked #2880
- 2004Entered Top 25% NationallyRanked #2880
- 2005$2M Cumulative Funding